Medical School
- MD, Northwestern University The Feinberg School of Medicine (2016)
Graduate School
- MPH, George Washington University,The (2020)
Undergraduate School
- BS, Andrews University (MI) (2012)
Internship
- Loyola University Medical Center (2017)
Residency
- Loyola University Medical Center, Chief Resident, Internal Medicine (2019)
Fellowships
- University of Colorado (University Hospital) Program, Pulmonary Disease and Critical Care Medicine (2023)
- University of Colorado (University Hospital) Program, Pulmonary Vascular Research (2024)
Department
Medicine-Pulmonary Sciences & Critical CareRecognitions
- Butrous Foundation Young Investigator Award, Pulmonary Vascular Research Institute (2026)
- CU Trainee Research Excellence Award, University of Colorado Anschutz (2024)
- Respiratory Disease Young Investigator Forum, Basic Science award, National Jewish (2023)
- Minority Training Development Scholarship, American Thoracic Society (2022)
- SfRBM DEI Award, Society for Redox Biology and Medicine (2022)
- Gold Humanism Society Inductee, Gold Humanism Society (2021)
Research Interests
My research focuses on understanding the mechanisms underlying pulmonary vascular disease, with an emphasis on pulmonary hypertension. I study how oxidative stress, inflammation, and platelet dysfunction contribute to pulmonary vascular remodeling and right ventricular dysfunction, with the goal of identifying novel therapeutic targets. My work integrates translational laboratory models with clinically relevant questions to advance the treatment of patients with pulmonary vascular disease.Publications
- Murray M, Kang H, Ok T, Park K, Lee JJY, Kim B, Sung H, Tait T, Hidalgo DC, Guzman Y. Docosahexaenoic acid modulates myo-inositol and myo-inositol biosynthetic genes expression: implications for bipolar disorder. Pharmacol Rep. 2026 Jan 5. [Epub ahead of print] PubMed PMID: 41489728
- Lewis CV, Nguyen TN, Porfilio TE, Burciaga SD, Posey JN, Jordan M, Colon Hidalgo D, Stenmark KR, Mickael C, Sul C, Oberley-Deegan RE, Delaney C, Nozik ES. Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia. Am J Physiol Lung Cell Mol Physiol. 2025 Jun 1;328(6):L885-L900. PubMed PMID: 40332405
- Nguyen TN, Lewis CV, Hidalgo DC, Posey JN, Jordan M, Porfilio TE, Grayck MR, Wright CJ, Delaney C, Nozik ES. A maternal hypoxia mouse model to study the effect of late gestational hypoxia on offspring lung outcomes. Front Physiol. 2025;16:1513703. PubMed PMID: 40084179
- Sul C, Lewis CV, Posey J, Jordan M, Colon Hidalgo D, Porfilio T, Elajaili H, McCormack G, Burciaga S, Delaney C, Nozik ES. Increased Circulating Extracellular Superoxide Dismutase Attenuates Platelet-Neutrophil Interactions. Am J Respir Cell Mol Biol. 2025 Jun;72(6):653-662. PubMed PMID: 39531632
- Colon Hidalgo D, Calhoun K, Neumeier A. Cultivating Diversity, Equity, and Inclusion in Pulmonary and Critical Care Training: A Path Toward Health Care Excellence. Crit Care Clin. 2024 Oct;40(4):789-803. PubMed PMID: 39218486
- Sul C, Lewis CV, Posey J, Jordan M, Colon Hidalgo D, Porfilio T, Elajaili H, McCormack G, Burciaga S, Delaney C, Nozik ES. Increased Circulating Extracellular Superoxide Dismutase Attenuates Platelet-Neutrophil Interactions. Am J Respir Cell Mol Biol. 2024 Nov 12. [Epub ahead of print] PubMed PMID: 39531632
- Colon Hidalgo D, Jordan M, Posey JN, Burciaga SD, Nguyen TN, Sul C, Lewis CV, Delaney C, Nozik ES. Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation. Antioxidants (Basel). 2024 Aug 10;13(8). PubMed PMID: 39199221
- Colon Hidalgo D, Ramos KJ, Harlan EA, Holguin F, Forno E, Weiner DJ, Griffith MF. Historic Use of Race-Based Spirometry Values Lowered Transplant Priority for Black Patients. Chest. 2024 Feb;165(2):381-388. PubMed PMID: 37832783
- Rollin FG, Mould KJ, Colon Hidalgo D. Racial disparities in cardiovascular outcomes are windows into structural racism, not genetics. Sleep Med. 2023 May;105:85. PubMed PMID: 36966580
- Colon Hidalgo D. To the Editor. Heart Lung. 2023 Jan-Feb;57:299. PubMed PMID: 36153286
- Patel JS, Colon Hidalgo D, Capistrano I, Mancl E, Rech MA. Antihypertensive Medications Prior to Shock Onset Do Not Impact Initial Vasopressor Requirements in Patients With Shock. J Pharm Pract. 2023 Apr;36(2):342-349. PubMed PMID: 34601987
- Colon Hidalgo D, Menich BE, Lovett S, Rech MA. The incidence and characteristics of bacteremia in cardiac arrest. Heart Lung. 2022 Mar-Apr;52:106-109. PubMed PMID: 34953363
- Tapaskar N, Colon Hidalgo D, Koo G, Shingada K, Rao S, Rodriguez R, Alcantar D, Espinoza Barrera D, Lee R, Rameshkumar N, Amine M, Rodrigues S, Giron F, Chaugule A, Rech MA. Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study. Ann Pharmacother. 2022 Feb;56(2):117-123. PubMed PMID: 34075807
- Hidalgo DC, Amin V, Hukku A, Kutlu K, Rech MA. Etomidate Use for Rapid Sequence Intubation Is Not Associated With Nosocomial Infection. J Pharm Pract. 2022 Jun;35(3):383-387. PubMed PMID: 33302788
- Hidalgo DC, Olusanya O, Harlan E. Critical care trainees call for pulse oximetry reform. Lancet Respir Med. 2021 Apr;9(4):e37. PubMed PMID: 33662275
- Colon Hidalgo D, McElroy I. Racial Trauma Perpetuated by Academic Medicine to Those in Its Ranks. Ann Am Thorac Soc. 2021 Nov;18(11):1773-1775. PubMed PMID: 34237227
- Colon Hidalgo D, Tapaskar N, Rao S, Masic D, Su A, Portillo J, Rech M. Lower socioeconomic factors are associated with higher mortality in patients with septic shock. Heart Lung. 2021 Jul-Aug;50(4):477-480. PubMed PMID: 33831699
- Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care. 2020 Feb;55:145-148. PubMed PMID: 31731173
- Rech MA, Colon Hidalgo D, Larson J, Zavala S, Mosier M. Vitamin D in burn-injured patients. Burns. 2019 Feb;45(1):32-41. PubMed PMID: 29776863
- Heymann HB, Colon DA, Jampol LM. ACUTE IDIOPATHIC MACULOPATHY: 7-YEAR FOLLOW-UP WITH DEVELOPMENT OF OUTER RETINAL TUBULATIONS. Retin Cases Brief Rep. 2019 Summer;13(3):224-226. PubMed PMID: 28248743
- Masic D, Hidalgo DC, Kuhrau S, Chaney W, Rech MA. Pharmacist Presence Decreases Time to Prothrombin Complex Concentrate in Emergency Department Patients with Life-Threatening Bleeding and Urgent Procedures. J Emerg Med. 2019 Nov;57(5):620-628. PubMed PMID: 31447188
- Simonett JM, Chan EW, Chou J, Skondra D, Colon D, Chee CK, Lingam G, Fawzi AA. Quantitative Analysis of En Face Spectral-Domain Optical Coherence Tomography Imaging in Polypoidal Choroidal Vasculopathy. Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):126-133. PubMed PMID: 28195615
- Heymann HB, Colon D, Gill MK. Choroidal neovascularization secondary to tubulointerstitial nephritis and uveitis syndrome (TINU) in an adult patient. J Ophthalmic Inflamm Infect. 2015 Dec;5(1):29. PubMed PMID: 26446047
Practice Locations
UCHealth University of Colorado Hospital (UCH)12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties- Internal Medicine, Board Certification (2019)
- Pulmonary Disease, Board Certification (2023)
- Critical Care Medicine, Board Certification (2024)
- Critical Care
- Lungs and Breathing - Pulmonary Hypertension
- Lungs and Breathing
- Lungs and Breathing - Pulmonary Embolism
Care Philosophy
I believe the best patient care begins with listening. I strive to build collaborative relationships with patients and their families, ensuring they understand their diagnosis, treatment options, and goals of care. My approach combines evidence-based medicine with individualized treatment plans that reflect each patient's unique needs and values. As a physician and scientist, I am committed to translating scientific advances into better care for patients with complex pulmonary vascular and critical care illnesses.
I believe the best patient care begins with listening. I strive to build collaborative relationships with patients and their families, ensuring they understand their diagnosis, treatment options, and goals of care. My approach combines evidence-based medicine with individualized treatment plans that reflect each patient's unique needs and values. As a physician and scientist, I am committed to translating scientific advances into better care for patients with complex pulmonary vascular and critical care illnesses.